share_log

药康生物(688046.SH)发布半年度业绩,净利润7634万元,同比下降1.59%

Yao Kang Biology (688046.SH) released its semi-annual performance, with a net income of 76.34 million yuan, a year-on-year decrease of 1.59%.

Zhitong Finance ·  Aug 28 07:06

Yao Kang Biology (688046.SH) disclosed its semi-annual report for 2024, and the company achieved revenue of 0.34 billion during the reporting period...

Smart Finance app news, Yao Kang Biology (688046.SH) disclosed its semi-annual report for 2024, and the company achieved revenue of 0.34 billion yuan, a year-on-year increase of 15.05%; net income attributable to shareholders was 76.34 million yuan, a year-on-year decrease of 1.59%; non-deductible net income was 54.84 million yuan, a year-on-year increase of 10.73%; basic earnings per share was 0.19 yuan. It is planned to distribute a cash dividend of 0.30 yuan (tax included) per 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment